• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Pulmonology

Midazolam reduces respiratory variability in women with fibromyalgia compared with S-ketamine

byPaary BalakumarandSimon Pan
January 13, 2026
in Pulmonology
Reading Time: 2 mins read
Midazolam reduces respiratory variability in women with fibromyalgia compared with S-ketamine
Share on FacebookShare on TwitterShare on LinkedIn

1. Midazolam significantly reduces respiratory variability, leading to a more uniform and less adaptable breathing pattern, which may increase risk in patients with compromised respiratory function.

2. S-ketamine largely preserves respiratory variability, suggesting it may be a safer sedative option for patients who require maintenance of spontaneous breathing.

Evidence Rating Level: 1 (Excellent) 

This randomized controlled pilot trial investigated the effects of s-ketamine and midazolam on respiratory variability, an indicator of adaptability of the respiratory system, in women with fibromyalgia. Twenty-eight participants were randomized to receive intravenous infusions of s-ketamine, midazolam, or saline in a blinded, crossover design across three visits. Respiratory parameters, including mean respiratory rate, variability of respiratory rate, and variability of tidal volume, were continuously measured non-invasively using a bio-impedance method. Data from 57 experimental sessions were analyzed with linear mixed models. Midazolam significantly reduced both respiratory rate variability by 37% and tidal volume variability by 51%, without affecting mean respiratory rate. S-ketamine produced a smaller reduction in tidal volume variability (27%) but did not affect respiratory rate variability. Post hoc analysis confirmed significant differences between the two drugs across all parameters. The findings suggest that midazolam induces a more regular and less adaptable breathing pattern, whereas s-ketamine largely preserves respiratory variability. These results have clinical implications in anesthesiology and critical care, as preserved variability may be advantageous for patients requiring sedation while maintaining spontaneous breathing. Further studies in larger and more diverse patient populations are needed to determine the clinical significance of these differential effects.

Click to read this study in PLOS One

Image: PD

RELATED REPORTS

Artificial intelligence (AI)-triggered rapid response notifications were associated with lower mortality among inpatients

Bougie-guided and stylet-guided intubation may have similar success rate in the intubation of trauma patients

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: anesthesiologycritical careesketaminemidazolampulmonology
Previous Post

2MM: AI Roundup –Dermatology accuracy, faster drug discovery, heart disease detection, and global medical training [September 11th,  2025]

Next Post

Artificial intelligence accelerates drug discovery and reduces animal testing

RelatedReports

A depiction of a heart, a vaccine vial, and a COVID-19 virus, with an ECG waveform in the background.
Artificial Intelligence

Artificial intelligence (AI)-triggered rapid response notifications were associated with lower mortality among inpatients

October 2, 2026
Postextubation administration of high-flow oxygen leads to reduced reintubation and respiratory failure
Emergency

Bougie-guided and stylet-guided intubation may have similar success rate in the intubation of trauma patients

August 11, 2026
Antiarrhythmic drugs have no survival benefit in shock-refractory out-of-hospital cardiac arrest
Cardiology

Resuscitative endovascular balloon occlusion of the aorta may not improve outcomes in adults with non-traumatic out-of-hospital cardiac arrest

May 14, 2026
Obstetric scoring systems overestimate cases of severe sepsis
Infectious Disease

Fluoxetine may improve hemodynamic status and organ dysfunction in patients with severe sepsis

January 29, 2026
Next Post
Variation noted across pre- and post-marketing studies for FDA approved devices

Artificial intelligence accelerates drug discovery and reduces animal testing

Physical therapy reduces pain in adults with knee osteoarthritis

Use of a valgus brace may reduce knee pain in knee osteoarthritis

2 Minute Medicine Rewind September 15, 2025

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Zanidatamab-hrii combinations improved survival in first-line HER2-positive advanced gastroesophageal adenocarcinoma
  • Upacicalcet reduced parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism in PATH-1 and PATH-2
  • WGS Oncodetect showed higher recurrence sensitivity than WES Oncodetect in colorectal cancer
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.